Risk of Lactic Acidosis or Elevated Lactate Concentrations in Metformin Users With Renal Impairment: A Population-Based Cohort Study
Open Access
- 12 July 2014
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 37 (8) , 2218-2224
Abstract
OBJECTIVE The objective of this study was to determine whether treatment with metformin in patients with renal impairment is associated with a higher risk of lactic acidosis or elevated lactate concentrations compared with users of a noninsulin antidiabetic drug (NIAD) who had never used metformin. RESEARCH DESIGN AND METHODS A cohort of 223,968 metformin users and 34,571 diabetic patients who had never used metformin were identified from the Clinical Practice Research Datalink (CPRD).The primary outcome was defined as either a CPRD READ code lactic acidosis or a record of a plasma lactate concentration >5 mmol/L. The associations between renal impairment, dose of metformin, and the risk of lactic acidosis or elevated lactate concentrations were determined with time-dependent Cox models and expressed as hazard ratios (HRs). RESULTS The crude incidence of lactic acidosis or elevated lactate concentrations in current metformin users was 7.4 per 100,000 person-years (vs. 2.2 per 100,000 person-years in nonusers). Compared with nonusers, risk of lactic acidosis or elevated lactate concentrations in current metformin users was significantly associated with a renal function 2 g) of metformin (adjusted HR 13.0 [95% CI 2.36–72.0]). CONCLUSIONS Our study is consistent with current recommendations that the renal function of metformin users should be adequately monitored and that the dose of metformin should be adjusted, if necessary, if renal function falls below 60 mL/min/1.73 m2.Keywords
This publication has 25 references indexed in Scilit:
- The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosisBMC Pharmacology and Toxicology, 2013
- The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of PathogenesisDrug Safety, 2013
- Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes RegisterBMJ Open, 2012
- Metformin in patients with chronic kidney disease: strengths and weaknessesJournal Of Nephrology, 2012
- Use of Metformin in the Setting of Mild-to-Moderate Renal InsufficiencyDiabetes Care, 2011
- Use of Metformin in Patients with Kidney and Cardiovascular DiseasesCardiorenal Medicine, 2011
- Metformin-Associated Acute Kidney Injury and Lactic AcidosisInternational Journal of Nephrology, 2011
- Outcome of severe lactic acidosis associated with metformin accumulationCritical Care, 2010
- Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or HypoglycemiaDiabetes Care, 2008
- Lactic Acidosis in Metformin-Treated PatientsDrug Safety, 1999